Syneos Health Inc.’s SYNH stock surged 19% in extended trading Tuesday on a Bloomberg report that a consortium of Elliott Investment Management, Patient Square Capital and Veritas Capital is in advanced talks to acquire Syneos, a drug-research services company. A deal could be announced as soon as this week, according to people with knowledge of the talks, the report said.
…
